Problems with drug-eluting coronary stents--the FDA perspective.
Muni
Neal I
NI
Center for Devices and Radiological Health, Food and Drug Administration, Rockville, Md, USA.
Gross
Thomas P
TP
D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation*; D003327:Coronary Disease / Q000628:therapy; D018795:Device Approval; D016503:Drug Delivery Systems; D004868:Equipment Failure; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use; D011474:Prosthesis Design; D020123:Sirolimus / Q000627:therapeutic use; D015607:Stents / Q000009:adverse effects* / Q000592:standards; D013927:Thrombosis / Q000209:etiology*; D014481:United States; D014486:United States Food and Drug Administration
D017239:Paclitaxel; D020123:Sirolimus